These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 22252844

  • 1. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 2. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 3. In crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression.
    Bazzi C, Rizza V, Raimondi S, Casellato D, Napodano P, D'Amico G.
    Clin J Am Soc Nephrol; 2009 May; 4(5):929-35. PubMed ID: 19406958
    [Abstract] [Full Text] [Related]

  • 4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 5. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP, van den Brand JA, Wetzels JF.
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [Abstract] [Full Text] [Related]

  • 8. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate.
    Okonogi H, Utsunomiya Y, Miyazaki Y, Koike K, Hirano K, Tsuboi N, Suzuki T, Hara Y, Ogura M, Hosoya T, Kawamura T.
    Nephron Clin Pract; 2011 Feb; 118(3):c292-300. PubMed ID: 21212693
    [Abstract] [Full Text] [Related]

  • 9. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC, Liem M, de Jager DJ, Voormolen N, Sijpkens YW, Rotmans JI, Boeschoten EW, Dekker FW, Grootendorst DC, Halbesma N, PREPARE-1 Study Group.
    Nephron Clin Pract; 2012 Feb; 121(1-2):c73-82. PubMed ID: 23128440
    [Abstract] [Full Text] [Related]

  • 10. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Feb; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

  • 12. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R, Ferjuc A, Furman B, Gerjevič Š, Bevc S, Hojs R.
    Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
    [Abstract] [Full Text] [Related]

  • 13. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Apr; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 15. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 16. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S, Söderberg MP, Berg UB.
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [Abstract] [Full Text] [Related]

  • 17. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X, Chen X, Liu S, Zhuang Y, Zhang Y.
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [Abstract] [Full Text] [Related]

  • 18. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.
    Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
    [Abstract] [Full Text] [Related]

  • 19. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy.
    Lundberg S, Gunnarsson I, Jacobson SH.
    Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235
    [Abstract] [Full Text] [Related]

  • 20. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.